Target Name: T-Type Calcium Channel
NCBI ID: P11019
Review Report on T-Type Calcium Channel Target / Biomarker Content of Review Report on T-Type Calcium Channel Target / Biomarker
T-Type Calcium Channel
Other Name(s): T-Type Ca2+ Ch

T-Type Calcium Channel (T-Type Ca2+ Ch): A Promising Drug Target and Biomarker

Abstract:
T-type calcium channels (T-Type Ca2+ Ch) play a crucial role in various physiological processes, including muscle contractions, nerve function, and brain activity. Imbalances in T-Type Ca2+ Ch activity have been associated with various neurological and cardiovascular disorders. This review focuses on the current understanding of T-Type Ca2+ Ch, its functions, and potential as a drug target and biomarker.

Introduction:
Ca2+ ions are essential for many physiological processes, including muscle contractions, nerve function, and brain activity. They are the main intracellular signaling molecules in eukaryotic cells and play a pivotal role in regulating a wide range of cellular processes. The regulation of Ca2+ ions is critical for maintaining cellular homeostasis and for the proper functioning of various organ systems.

T-Type Ca2+ Ch:
T-type calcium channels, also known as T-type ATP-dependent channels, are a subclass of calcium channels that are primarily found in cardiac and skeletal muscles. They are characterized by the presence of a unique protein called the T-type Ca2+ channel subunit (T-Type Ca2+ Ch) and are responsible for the rapid and efficient regulation of Ca2+ ions in these cells.

T-Type Ca2+ Ch Functions:
T-Type Ca2+ Ch is involved in various physiological processes that are critical for maintaining cellular homeostasis. They play a key role in muscle contractions by regulating the rapid Ca2+ ions entering the muscle fibers, which is essential for muscle relaxation and force production. T-Type Ca2+ Ch is also involved in the regulation of nerve function, as they play a critical role in the rapid and efficient transmission of action potentials.

T-Type Ca2+ Ch as a Drug Target:
T-Type Ca2+ Ch has been identified as a potential drug target due to its unique biology and the impact it has on various physiological processes. The inhibition of T-Type Ca2+ Ch has been shown to have a wide range of therapeutic potential, including the treatment of various neurological and cardiovascular disorders.

T-Type Ca2+ Ch as a Biomarker:
T-Type Ca2+ Ch has also been used as a biomarker for various physiological processes, including muscle function and nerve activity. The levels of T-Type Ca2+ Ch in muscle fibers have been shown to be closely correlated with the levels of muscle activity, making them an attractive biomarker for the study of muscle physiology.

Conclusion:
T-Type Ca2+ Ch is a crucial protein for the regulation of Ca2+ ions and plays a critical role in various physiological processes. Its inhibition has been shown to have a wide range of therapeutic potential, making it an attractive drug target and biomarker. Further research is needed to fully understand the functions of T-Type Ca2+ Ch and its potential as a drug.

Protein Name: T-Type Calcium Channel

The "T-Type Calcium Channel Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about T-Type Calcium Channel comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

TAAR1 | TAAR2 | TAAR3P | TAAR5 | TAAR6 | TAAR8 | TAAR9 | TAB1 | TAB2 | TAB2-AS1 | TAB3 | TAC1 | TAC3 | TAC4 | TACC1 | TACC2 | TACC3 | Tachykinin Receptor | TACO1 | TACR1 | TACR2 | TACR3 | TACSTD2 | TADA1 | TADA2A | TADA2B | TADA3 | TAF1 | TAF10 | TAF11 | TAF11L2 | TAF11L3 | TAF12 | TAF12-DT | TAF13 | TAF15 | TAF1A | TAF1A-AS1 | TAF1B | TAF1C | TAF1D | TAF1L | TAF2 | TAF3 | TAF4 | TAF4B | TAF5 | TAF5L | TAF5LP1 | TAF6 | TAF6L | TAF7 | TAF7L | TAF8 | TAF9 | TAF9B | TAFA1 | TAFA2 | TAFA3 | TAFA4 | TAFA5 | TAFAZZIN | TAGAP | TAGAP-AS1 | TAGLN | TAGLN2 | TAGLN3 | TAK1 | TAL1 | TAL2 | TALDO1 | TAM Receptor tyrosine kinase | TAMALIN | TAMM41 | TANC1 | TANC2 | TANGO2 | TANGO6 | TANK | Tankyrase | TAOK1 | TAOK2 | TAOK3 | TAP1 | TAP2 | TAPBP | TAPBPL | TAPT1 | TAPT1-AS1 | TARBP1 | TARBP2 | TARDBP | TARDBPP1 | TARDBPP3 | TARID | TARM1 | TARP | TARS1 | TARS2 | TARS3